GPCM
TECX

Granite Point Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Granite Point Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,000
Closed -$976K – 94
2019
Q2 		$976K Buy
+5,000
New +$1.08M 0.07% 63

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Granite Point Capital Management's TECX Position: Q3 2019 in Review

Granite Point Capital Management sold out of Tectonic Therapeutic (TECX) in Q3 2019, closing a stake of 5,000 shares — an estimated $976K sold.

Granite Point Capital Management first reported a position in TECX in Q2 2019 and held it in 1 quarter. The position peaked at $976K in Q2 2019. 85 funds tracked by Wall St. Rank hold TECX as of Q3 2019.

  • Granite Point Capital Management reported no remaining Tectonic Therapeutic position as of Q3 2019 after selling out during the quarter.
  • Granite Point Capital Management sold 5,000 Tectonic Therapeutic shares in Q3 2019, an estimated $976K.
  • Granite Point Capital Management first reported a position in Tectonic Therapeutic in Q2 2019 and held it in 1 quarter.
  • Granite Point Capital Management's Tectonic Therapeutic position peaked at $976K in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2019.

Based on Granite Point Capital Management's 13F filing for Q3 2019, filed 30 Oct 2019.